Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- -$1K to -$15K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 6 cutMore cutting
Key stats
Fundamentals Sep 30- Open
- $98.24
- 52-wk high
- $117.37
- High
- $99.01
- 52-wk low
- $90.09
- Low
- $97.50
- Prev close
- $98.77
- Mkt cap
- $32.92B
- P/E
- 19.5x
- Volume
- 2.70M
- Fwd P/E
- 13.1x
- Beta
- 0.27
- Div yield
- 5.14%
- P/S
- 2.0x
- P/B
- 18.8x
- Profit margin
- +11.8%
- Op margin
- +19.0%
- ROE
- +104.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about KMB filings
Are insiders buying or selling Kimberly-Clark Corporation (KMB) stock?
Neither. Kimberly-Clark Corporation (KMB) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded KMB recently?
Rep. Kevin Hern (R) sold $1K to $15K on Aug 18, 2026, disclosed 14 days later. In total, 1 member disclosed 1 KMB trade with trade dates in the last 180 days, filed a median 14 days after trading.
How current is this KMB smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- CI

Citadel
$63.7M
added
Sells/Trims (2)
- DS

D.E. Shaw
$106.3M
trimmed
- P7

Point72
$76.8M
sold
What insiders are doing
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in KMB right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 10.0% below what analysts expected.
Earnings per share
$2.00 expected
Revenue
$4.22B expected
GAAP EPS was $1.22 and adjusted EPS was $1.80. The adjusted figure is comparable to consensus.
Reports Oct 29, 2026, in 28 days
Estimates as of Sep 30, 2026
EPS expected
$1.62 to $1.79
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.13B | $4.08B | $4.16B | $4.19B |
| Cost of what it sold | $2.66B | $2.62B | $2.63B | $2.59B |
| Gross profit | $1.48B | $1.47B | $1.53B | $1.60B |
| What it spent | ||||
| Sales and admin | $855.0M | $955.0M | $920.0M | $1.00B |
| Other operating costs | — | — | $139.0M | $151.0M |
| Total operating expenses | $855.0M | $958.0M | $1.06B | $1.16B |
| What was left | ||||
| Operating profit | $621.0M | $507.0M | $475.0M | $448.0M |
| Interest on debt | $65.0M | $60.0M | $58.0M | $53.0M |
| Profit before tax | $592.0M | $436.0M | $685.0M | $572.0M |
| Tax | $248.0M | $45.0M | $164.0M | $217.0M |
| Net profit | $446.0M | $499.0M | $665.0M | $345.0M |
| EBITDA | $833.0M | $685.0M | $743.0M | $792.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Kenvue: Neutrogena, Aveeno, and Regaine Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
NeutralSep 30Kimberly Clark (KMB) Stock Still Looks Cheap Despite A 16% Slump
NeutralSep 30Kimberly-Clark Pays Out Almost Everything It Earns. Can the Dividend Survive the Kenvue Deal?
Leans bearishSep 29Kimberly-Clark Pays Out Almost Everything It Earns. Can the Dividend Survive the Kenvue Deal?
Leans bearishSep 293 CPGs discuss automation, sourcing and logistics risks
Leans bearishSep 29Procter & Gamble (PG) Stock May Be 24% Undervalued After Q1 Sales Slip
NeutralSep 29How Purell ProCare Launch At Clorox Stock Has Changed Its Investment Story
NeutralSep 29Form 8K Kimberly-Clark Corp For: 28 September By Investing.com
NeutralSep 29
Macro
33 macro signals shaping KMB right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results